Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

AGM Statement

18 Jun 2018 07:00

RNS Number : 6700R
Directa Plus PLC
18 June 2018
 

18 June 2018

 

Directa Plus plc

("Directa Plus" or the "Company")

 

AGM Statement

 

Directa Plus (AIM: DCTA), a producer and supplier of graphene-based products for use in consumer and industrial markets, announces that at the Annual General Meeting of the Company, which is being held today at 3.30pm, Sir Peter Middleton, Chairman of Directa Plus, will make the following statement.

 

"During 2017 we made significant commercial progress across our four key target markets and I am pleased to report that this momentum has continued into 2018. We have a strong pipeline of opportunities for near term commercial progress and continue to broaden our portfolio of patents with two patents granted in 2018 covering our non-toxic flame retardancy composition for the textiles market and our new graphene-based solution for enhancing the performance of tyres, which were awarded by the US and Italian patent offices respectively. Both of these offer significant market opportunities and have already stimulated substantial interest in the capabilities of our graphene nanoplatelets (G+ materials).

 

 "It is testament to our position within the industry that the National Graphene Association, the main organisation and body in the US advocating and promoting the commercialisation of graphene and addressing critical issues such as standards and policy development, has invited Directa Plus to join as a new Corporate Partner and for Giulio Cesareo to join the Advisory Board.

 

"Now turning to the progress in our key target markets.

 

"In the Environmental sector, Grafysorber® is the only commercially-available graphene-based solution for treating produced water in the oil & gas industry - making it a disruptive product with a very substantial market opportunity.

 

"We achieved a significant milestone in March 2018 with the signing of a commercial agreement with Sartec Srl (part of Saras Group, one of the largest refineries in Europe) to jointly develop and promote a continuous commercial-scale industrial system using Grafysorber® for treating oil-contaminated produced water in the oil & gas industry. We are making good progress in building this plant and are in discussions with Sartec on the options for establishing an operational structure to commercialise the process going forward.

 

"Work continues with two leading Romanian integrated oil & gas companies for field testing Grafysorber® for treating oil-contaminated water. OMV Petrom have completed industrial testing for continuous treatment at an oil treatment plant and for oil spill remediation with excellent results. Trials are underway with GSP SA, with good results to date.

 

"In the Textiles sector, the benefits of our chemical-free G+ are widely understood and we are increasingly engaging with global brand owners and textile companies who want to enhance the performance of their end products through leveraging its bacteriostatic, thermal management and fire retardant properties. As a result, we continue to add new customers as well as having current customers launch larger numbers of graphene-enhanced products into the market.

 

"A key development in this market is our recent signing of an exclusive collaboration agreement with Arvind Limited, a leading textile-to-retail-and-brands conglomerate in India, to infuse the high-performance benefits of G+ into their denim fabrics. Each year Arvind produces over 100 million metres of fabrics and 6 million pairs of jeans and with a portfolio of brands including Gant, Levi's, Nautica, Tommy Hilfiger and Wrangler. This represents a substantial opportunity for Directa Plus. Significant activity is already underway and we expect that the relationship will be broadened to include Arvind's other textile segments (workwear) as well as other business areas within the wider Arvind group.

 

"We also continue to be very excited about the opportunities that our relationship with Alfredo Grassi could yield for Directa Plus. Grassi has a leading market position in the provision of workwear and customised uniforms across a range of sector verticals, and we are working closely to seek to expand the incorporation of G+ into these other markets.

 

"Finally, in our Elastomers and Composite Materials sectors, this year we entered into a strategic collaboration with Marangoni, a global leader in the tyre retreading industry, to develop a bespoke version of our G+ to improve the performance of Marangoni compounds in truck and bus tyre retreading. The incorporation of G+ offers both economic and environmental benefits for tyre retreading - representing a substantial market opportunity. This is an important milestone as we leverage the know-how and experience gained in the bike tyre industry to transition into the automotive markets, which we believe is a key target market for future growth. Initial testing is already underway, with excellent results, and road tests are planned for later this year.

 

"In other Elastomer and Composite activities, we have received a third order for G+ from a leading manufacturer of brake pads; and we are actively engaging with a range of automotive customers who are increasingly recognising the significant performance benefits offered by G+.

 

"This substantial activity across our key markets would not be possible without our proprietary chemical-free production process. This process enables us to produce consistent G+ materials, to control material thickness and aspect ratio as well as offering single layer graphene so as to meet the exact technical requirements of our existing and potential customers.

 

"With more and more customers preparing to launch products incorporating G+, we remain confident of securing future orders and delivering significant progress in full year 2018 and beyond. The opportunities for G+ remain substantial and we are focused on leveraging our strong market position and investing in our sales efforts to realise these significant commercial opportunities. I thank you, our shareholders, for your continuing support and I look forward to reporting on our continued commercial progress."

 

 

Enquiries

 

Directa Plus plc

Giulio Cesareo, CEO

Marco Ferrari, CFO

+39 02 36714458

Cantor Fitzgerald Europe (Nominated Adviser and Broker)

Marc Milmo, David Foreman (Corporate Finance)

Alex Pollen, Caspar Shand Kydd (Sales)

+44 20 7894 7000

Luther Pendragon (Financial PR)

Harry Chathli, Claire Norbury, Alexis Gore

+44 20 7618 9100

 

 

About Directa Plus

 

Directa Plus is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets worldwide. By incorporating Directa Plus' unique graphene blends, identified by the G+ brand, its customers can enhance the performance of their end products without significantly increasing their cost. Directa Plus graphene-based products are natural, chemical-free, sustainably produced and tailored to specific customer requirements for commercial applications such as smart textiles, tyres, composite materials and environmental solutions. 

 

Established in 2005, the Company has a patented technology process and a portfolio of product and application patents. It produces its graphene-based products at its own factory in Lomazzo, Italy, with a scalable and exportable manufacturing model enabling the set-up of additional production at customer locations to reduce transport costs, waste and time-to-utilisation. Directa Plus partners with customers to enable them to offer the high-performance benefits of graphene in their own products.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMEAFKXFLAPEAF
Date   Source Headline
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave
28th Feb 20224:50 pmRNSExercise of Options
8th Feb 20225:20 pmRNSHolding(s) in Company
29th Dec 202111:11 amRNSResult of General Meeting & TVR
20th Dec 20217:00 amRNSGrant of EU Patent for Shoe Soles
10th Dec 20215:00 pmRNSPosting of Circular and Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.